NASDAQ:NRBO +750% Potential Upside - Reversal. It is squeezing almost a year. It is about time for reversal. With volume, it would run multi days.
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company that develops and commercializes multimodal disease-modifying therapies for viral, neuropathic, and neurodegenerative diseases. It develops ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic...
Here is NRBO since the violation of its major resistance is at a point of a massive breakout to the following targets. The recent volume within the load-zone is also indicating a bullish breakout to arrive.
On 4/20/2021 HC Wainwright brokerage Reiterated Rating to Buy and a Price Target of $16.00 for NRBO But how come? What`s the catalyst? Why NeuroBo Pharmaceuticals was up 40% yesterday? Richard J. Kang, CEO: "Throughout the first quarter of 2021, we continued to make progress advancing the 60-patient Phase 2/3 clinical trial of our lead drug candidate, ANA001,...
Pupm&Dump trading strategy idea. $NRBO is rising too much today. The demand for shares of the company looks lower than the supply. This and other conditions can cause a fall in the share price today. So I opened a short position from $3,69; stop-loss — $4,12; take-profit — $2,83. Do not view this idea as a recommendation for trading or investing. It is...
NeuroBo Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in developing and commercializing therapies for patients with diabetic neuropathy and Alzheimer's disease. Its product candidate comprises NB-01, which is primarily focused on the development of a treatment for painful diabetic neuropathy; NB-02, which treat the symptoms of...
Looks to have found a bottom around 4.8-5.2. Huge volume spike a few days ago, someone big probably built a position ahead of news. We'll see where this goes.